Transcripts

Capricor Therapeutics (CAPR) earnings call transcripts

Earnings call transcripts for Capricor Therapeutics, Inc., with a summary, the guidance given, and what analysts pressed on.

Open CAPR in Gloom →
Capricor Therapeutics' chart, financials and news, free in your browser.Open CAPR in Gloom →
  • Q2 2026 earnings call

    Management shifted the regulatory story from cardiomyopathy toward a potential upper-limb indication, while emphasizing uncertainty around FDA timing and containing spending.

    Aug 13, 2026Cautious-0.35